130 related articles for article (PubMed ID: 9020046)
1. The recombinant catalytic domain of mouse collagenase-3 depolymerizes type I collagen by cleaving its aminotelopeptides.
Lemaître V; Jungbluth A; Eeckhout Y
Biochem Biophys Res Commun; 1997 Jan; 230(1):202-5. PubMed ID: 9020046
[TBL] [Abstract][Full Text] [Related]
2. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.
Knäuper V; Cowell S; Smith B; López-Otin C; O'Shea M; Morris H; Zardi L; Murphy G
J Biol Chem; 1997 Mar; 272(12):7608-16. PubMed ID: 9065415
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen.
Steffensen B; Wallon UM; Overall CM
J Biol Chem; 1995 May; 270(19):11555-66. PubMed ID: 7744795
[TBL] [Abstract][Full Text] [Related]
4. Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins.
Sanchez-Lopez R; Alexander CM; Behrendtsen O; Breathnach R; Werb Z
J Biol Chem; 1993 Apr; 268(10):7238-47. PubMed ID: 8463259
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a rainbow trout matrix metalloproteinase capable of degrading type I collagen.
Saito M; Sato K; Kunisaki N; Kimura S
Eur J Biochem; 2000 Dec; 267(23):6943-50. PubMed ID: 11082208
[TBL] [Abstract][Full Text] [Related]
6. Defining requirements for collagenase cleavage in collagen type III using a bacterial collagen system.
Yu Z; Visse R; Inouye M; Nagase H; Brodsky B
J Biol Chem; 2012 Jun; 287(27):22988-97. PubMed ID: 22573319
[TBL] [Abstract][Full Text] [Related]
7. The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity.
Schnierer S; Kleine T; Gote T; Hillemann A; Knäuper V; Tschesche H
Biochem Biophys Res Commun; 1993 Mar; 191(2):319-26. PubMed ID: 8460992
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression and activation of a truncated 92-kDa gelatinase minienzyme.
Kröger M; Tschesche H
Gene; 1997 Sep; 196(1-2):175-80. PubMed ID: 9322755
[TBL] [Abstract][Full Text] [Related]
9. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library.
Deng SJ; Bickett DM; Mitchell JL; Lambert MH; Blackburn RK; Carter HL; Neugebauer J; Pahel G; Weiner MP; Moss ML
J Biol Chem; 2000 Oct; 275(40):31422-7. PubMed ID: 10906330
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain.
Fosang AJ; Last K; Knäuper V; Neame PJ; Murphy G; Hardingham TE; Tschesche H; Hamilton JA
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):273-6. PubMed ID: 8216228
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme.
Stracke JO; Hutton M; Stewart M; Pendás AM; Smith B; López-Otin C; Murphy G; Knäuper V
J Biol Chem; 2000 May; 275(20):14809-16. PubMed ID: 10809722
[TBL] [Abstract][Full Text] [Related]
12. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.
Mitchell PG; Magna HA; Reeves LM; Lopresti-Morrow LL; Yocum SA; Rosner PJ; Geoghegan KF; Hambor JE
J Clin Invest; 1996 Feb; 97(3):761-8. PubMed ID: 8609233
[TBL] [Abstract][Full Text] [Related]
13. Relation between substrate specificity and domain structure of 92-kDa type IV collagenase.
Pourmotabbed T
Ann N Y Acad Sci; 1994 Sep; 732():372-4. PubMed ID: 7978812
[No Abstract] [Full Text] [Related]
14. The expression, refolding, and purification of the catalytic domain of human collagenase-3 (MMP-13).
Pathak N; Hu SI; Koehn JA
Protein Expr Purif; 1998 Nov; 14(2):283-8. PubMed ID: 9790892
[TBL] [Abstract][Full Text] [Related]
15. Fragmentation of human polymorphonuclear-leucocyte collagenase.
Knäuper V; Osthues A; DeClerck YA; Langley KE; Bläser J; Tschesche H
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):847-54. PubMed ID: 8489511
[TBL] [Abstract][Full Text] [Related]
16. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix.
Kafienah W; Brömme D; Buttle DJ; Croucher LJ; Hollander AP
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):727-32. PubMed ID: 9560298
[TBL] [Abstract][Full Text] [Related]
17. Collagen-binding domain of human plasma fibronectin contains a latent type-IV collagenase.
Lambert Vidmar S; Lottspeich F; Emod I; Imhoff JM; Keil-Dlouha V
Eur J Biochem; 1991 Oct; 201(1):79-84. PubMed ID: 1655429
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan.
Fosang AJ; Last K; Neame PJ; Murphy G; Knäuper V; Tschesche H; Hughes CE; Caterson B; Hardingham TE
Biochem J; 1994 Dec; 304 ( Pt 2)(Pt 2):347-51. PubMed ID: 7998967
[TBL] [Abstract][Full Text] [Related]
19. Characterization of helical cleavages in type II collagen generated by matrixins.
Vankemmelbeke M; Dekeyser PM; Hollander AP; Buttle DJ; Demeester J
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):633-40. PubMed ID: 9480869
[TBL] [Abstract][Full Text] [Related]
20. The role of the C-terminal domain in collagenase and stromelysin specificity.
Murphy G; Allan JA; Willenbrock F; Cockett MI; O'Connell JP; Docherty AJ
J Biol Chem; 1992 May; 267(14):9612-8. PubMed ID: 1315762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
